Skip to content
Nandrolone decanoate
Deca-durabolin (nandrolone decanoate) is a small molecule pharmaceutical. Nandrolone decanoate was first approved as Nandrolone decanoate on 1983-09-28. It is used to treat anemia and breast neoplasms in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
neoplasmsD009369
hemic and lymphatic diseasesD006425
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Nandrolone decanoate
Tradename
Company
Number
Date
Products
DECA-DURABOLINWOODWARD SPECLN-013132 DISCN1986-06-12
3 products, RLD
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
anemiaEFO_0004272D000740D64.9
breast neoplasmsEFO_0003869D001943C50
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
Code
Description
J2320
Injection, nandrolone decanoate, up to 50 mg
Clinical
Clinical Trials
42 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Opioid-induced constipationD0000796891151614
ConstipationD003248HP_0002019K59.03223—9
NeoplasmsD009369C80———112
PainD010146EFO_0003843R52———1—1
Postoperative painD010149G89.18———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Critical illnessD016638——1——1
Brain injuriesD001930S06.9——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Urinary bladder neoplasmsD001749C67—1———1
Non-small-cell lung carcinomaD002289—1———1
GastroparesisD018589EFO_1000948K31.84—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients—5————5
Biological availabilityD0016822————2
Renal insufficiencyD051437HP_0000083N191————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameNANDROLONE DECANOATE
INN—
Description
Nandrolone decanoate is a steroid ester.
Classification
Small molecule
Drug classandrogens; steroids (not prednisolone derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C
Identifiers
PDB—
CAS-ID360-70-3
RxCUI31494
ChEMBL IDCHEMBL1200946
ChEBI ID7467
PubChem CID9677
DrugBankDB08804
UNII ID—
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 946 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
1,903 adverse events reported
View more details